The Drug Science Podcast14 Jul 2020

19. DMT with Chris Timmermann and Chloe Sakal

DMT is a drug that’s relatively novel in western neuropsychopharmacology. Not much research has been done on this substance to date and many intoxicants are unable to recount their psychedelic experience. For the first time, this substance is being studied in an fMRI and EEG to elucidate why and how this drug elucidates vivid dreams and near-death experiences.

Chris Timmerman recently completed his PhD in neuropsychopharmacology at Imperial College London, investigating the effects of psychedelic drugs in the human brain with Robin Carhart-Harris and David Nutt. He is developing his research with a focus on the effects of psychedelics in consciousness and brain connectivity. Chris recently lead a study involving the effects of DMT in the human brain and experience, while also understanding its potential use for mental health conditions.

Having gained a BSc in neuroscience, Dr Chloe Sakal went on to study medicine and gain membership with the Royal College of Psychiatrist. She has a keen interest in the psychopharmacology and the potential for the therapeutic use of psychedelic drugs in treating a wide range of psychiatric disorders. She is a study doctor for the UKs first MDMA-assisted psychotherapy trial looking at the safety and tolerability of its use in the treatment of alcoholism. She is an assistant-therapist on a phase two study looking at the treatment of psilocybin-assisted therapy for the treatment of depression. Alongside this, Chloe was a study participant in Chris Timmerman’s DMT research.

DMT Brain imaging study (Coming soon)

LSD brain imaging studies

Life After Life – Raymond Moody

5-MeO-DMT

Psychiachix

Become a Drug Science Community Member: https://www.donate.drugscience.org.uk/

Twitter: @ProfDavidNutt @Drug_Science

A Fascinate Productions podcast for Drug Science

★ Support this podcast ★

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(159)

156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda

In this episode, we speak with Dr Dixon Chibanda, a psychiatrist and professor at the London School of Hygiene and Tropical Medicine. He shares how losing a patient to suicide drove him towards commun...

5 Aug 41min

155. The History of Schizophrenia with Justin Garson

In this episode of the Drug Science Podcast, Dr Hannah Thurgur speaks with Dr Justin Garson, professor of philosophy at CUNY and the author of The Madness Pill, a history of Professor Solomon Snyder a...

22 Jul 47min

154. Is Medical Cannabis Over-Prescribed? with Dr Andy Barker

Join us in this episode as Prof Nutt speaks with Dr Andy Barker, a senior psychiatrist, medical cannabis prescriber, and the co-founder of This Native Mind. Andy shares his journey into medical cannab...

8 Jul 52min

153. Psychedelics, Couples and Sex with Sarah Tilley

In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led...

24 Jun 42min

152. Cocaine and Alcohol with David Hillier

In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David Hillier has been writing about drug culture and m...

10 Jun 38min

151. Francis Crick: From DNA to the Brain with Prof Matthew Cobb

In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into h...

27 Mai 57min

150. Synthetic Alcohol with David Orren

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial co...

13 Mai 57min

149. Psilocybin for Cancer with Dr Lauren Macdonald

In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that le...

29 Apr 54min